The Regulatory Questionnaire profile defines a structured, machine-readable format for regulatory questions issued by a health authority during the review of a regulatory submission. This resource enables automated routing, tracking, and response management while preserving rich formatting and traceability to the Common Technical Document (CTD) structure.
Participants & Contacts/div>
Scientific and Regulatory Management Division
EMA Amsterdam HQ
Global Regulatory Affairs Group
Basel, Switzerland
ISSUING AUTHORITY
European Medicines AgencyScientific and Regulatory Management Division
EMA Amsterdam HQ
RECIPIENT MAH
SynthPharma AGGlobal Regulatory Affairs Group
Basel, Switzerland
Module 1: Administrative Information
1
Is the variation fee fully paid and documented?
Confirmation of payment received by EMA Finance on Dec 20, 2024.
Module 3.2.P.7: Container Closure System
2
Any changes in the packaging configuration during stability?
[Draft Figure: Alu/Alu Blister Cross-section]
| Original Pack | Proposed Pack |
|---|---|
| PVC/PVDC Blister | Alu/Alu Blister |
Module 3: Quality - Stability
3
Are there any new stability studies conducted or only additional timepoints?
Reference: ICH Q1A(R2). Response provided on Dec 15, 2024.
4
Does the data support all intended climatic zones?
Confirm coverage for Zone IVb (30°C/75% RH) per WHO TRS 1010. Provide summary for all tested climatic conditions.